Melanoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Melanoma}} | {{Melanoma}} | ||
{{CMG}} {{AE}} {{YD}}; {{SSK}} | |||
==Overview== | |||
Chest positron emission tomography (PET) may be considered for diagnosis of metastatic lesions among patients who have been diagnosed with stage IV melanoma and for secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma.<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | |||
==Positron Emission Tomography (PET)== | |||
There are no chest PET findings associated with melanoma. | |||
*Chest PET may be considered for diagnosis of metastatic lesions in the following conditions:<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | |||
:*For patients who have been diagnosed with stage IV melanoma | |||
:*For secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 01:36, 22 August 2015
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Melanoma other imaging findings |
|
Risk calculators and risk factors for Melanoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
Chest positron emission tomography (PET) may be considered for diagnosis of metastatic lesions among patients who have been diagnosed with stage IV melanoma and for secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma.[1]
Positron Emission Tomography (PET)
There are no chest PET findings associated with melanoma.
- Chest PET may be considered for diagnosis of metastatic lesions in the following conditions:[1]
- For patients who have been diagnosed with stage IV melanoma
- For secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma
References
- ↑ 1.0 1.1 Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A; et al. (2013). "Melanoma, version 2.2013: featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (4): 395–407. PMID 23584343.